Acquiring Company
Bristol Myers Squibb
Acquired Company
Karuna Therapeutics
LawrencevilleBostonManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Bristol Myers Squibb has announced its acquisition of Karuna Therapeutics in a deal valued at approximately $14 billion. This acquisition is aimed at integrating Karuna's schizophrenia candidate, KarXT, into Bristol's neuroscience portfolio. The transaction, structured as an all-cash tender offer followed by a merger, is expected to close in 2024, pending regulatory approvals.
Fundz sees it the moment Bristol Myers Squibb makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Karuna Therapeutics?
Karuna Therapeutics was acquired by Bristol Myers Squibb, based in Lawrenceville. The deal was reported on May 14, 2026. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is publicly traded (BMY) and operates in Manufacturing.
When did Bristol Myers Squibb acquire Karuna Therapeutics?
Bristol Myers Squibb's acquisition of Karuna Therapeutics was reported on May 14, 2026. Bristol Myers Squibb has announced its acquisition of Karuna Therapeutics in a deal valued at approximately $14 billion. This acquisition is aimed at integrating Karuna's schizophrenia candidate, KarXT, into Bristol's neuroscience portfolio. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Karuna Therapeutics do?
Karuna Therapeutics, Inc. is a clinical-stage biotherapeutics company with a focus on developing innovative treatment options for patients with psychiatric and neurological conditions. It is privately held, operating in Biotechnology, and is based in Boston.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.